COGENTIX MEDICAL INC /DE/ - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 30, 2017

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - COGENTIX MEDICAL INC /DE/ex32_2.htm
EX-32.1 - EXHIBIT 32.1 - COGENTIX MEDICAL INC /DE/ex32_1.htm
EX-31.2 - EXHIBIT 31.2 - COGENTIX MEDICAL INC /DE/ex31_2.htm
EX-31.1 - EXHIBIT 31.1 - COGENTIX MEDICAL INC /DE/ex31_1.htm
EX-21.1 - EXHIBIT 21.1 - COGENTIX MEDICAL INC /DE/ex21_1.htm
EX-10.42 - EXHIBIT 10.42 - COGENTIX MEDICAL INC /DE/ex10_42.htm
EX-10.21 - EXHIBIT 10.21 - COGENTIX MEDICAL INC /DE/ex10_21.htm
EX-10.20 - EXHIBIT 10.20 - COGENTIX MEDICAL INC /DE/ex10_20.htm
EX-3.2 - EXHIBIT 3.2 - COGENTIX MEDICAL INC /DE/ex3_2.htm
10-K - COGENTIX MEDICAL INC 10-K 12-31-2016 - COGENTIX MEDICAL INC /DE/form10k.htm
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We have issued our report dated March 30, 2017, with respect to the consolidated financial statements and schedule included in the Annual Report of Cogentix Medical, Inc. and subsidiaries on Form 10-K for the year ended December 31, 2016.  We consent to the incorporation by reference of said report in the Registration Statement of Cogentix Medical, Inc. on Form S-8 (File No. 333-203135).

/s/ Grant Thornton LLP

Minneapolis, Minnesota
March 30, 2017
 
 

COGENTIX MEDICAL INC /DE/ Reports